Abstract:Background: Tripterygium wilfordii Hook. F (TwHF), a Chinese herbal medicine used to treat CTD-ILD patients in China, has been previously found to have immunoinhibitory, antifibrotic and anti inflammatory effects. It has also shown good results in treating autoimmune and inflammatory diseases. Objectives: This systematic review and meta-analysis aims to evaluate the efficacy and safety of TwHF for CTD-ILD. Methods: A systematic search was performed on PubMed, Embase, Cochrane Library, Web of Science, PsycINFO, Scopus, CNKI, Wanfang, VIP, and CBM databases up to May 2021. Randomized controlled trials (RCTs) comparing TwHF plus conventional therapy versus conventional therapy alone were included. We followed the PRISMA checklist, and applied Cochrane handbook 5.1.0 and RevMan 5.3 for data analysis and quality evaluation of the included studies. Results: Based on Cochrane handbook 5.1.0, nine RCTs consisting 650 patients met the inclusion/exclusion criteria and were selected for further analysis. The obtained data showed significant improvement in lung function with TwHF plus conventional treatment compared with conventional treatment (post-treatment FVC% (MD= 8.68, 95%Cl (5.10, 12.26), p < 0.00001), FEV1% (MD = 11.24, 95%Cl (6.87, 15.61), p < 0.00001), TLC% (MD = 5.28, 95%Cl (0.69, 9.87), p = 0.02)], but no significant difference in the post-treatment DLCO% [(MD = 4.40, 95%Cl (−2.29, 11.09), p = 0.20)]. Moreover, the data showed that TwHF combined with conventional treatment significantly reduced the HRCT integral of patients [MD = -0.65, 95% (-1.01, -0.30), p = 0.0003], the level of erythrocyte sedimentation rate (MD = −9.52, 95%Cl (−11.55, −7.49), p < 0.00001), c-reactive protein (CRP) (MD = −8.42, 95%Cl (−12.47, −4.38), p < 0.0001), and rheumatoid factor (MD = −25.48, 95%Cl (−29.36, −21.60), p < 0.00001). Compared to conventional therapy, TwHF combined with conventional therapy significantly improved clinical effects (RR = 1.33, 95%Cl (1.17, 1.51), p < 0.0001), in five trials with 354 patients. In terms of improvement of symptoms and signs, the TwHF group showed a more significant improvement than the conventional treatment group (Cough (MD = −0.96, 95%Cl (−1.43, −0.50), p < 0.0001), velcro rales (MD = −0.32, 95%Cl (−0.44, −0.20), p < 0.00001), shortness of breath (MD = −1.11, 95%Cl (−1.67, −0.56), p < 0.0001)], but no statistical difference in dyspnea (MD = −0.66, 95%Cl (−1.35, 0.03), p = 0.06). There was no statistical significance in the incidence of adverse reactions. Conclusion: The performed meta-analysis indicated that TwHF combined with conventional treatment was more beneficial to patients for improving symptoms, lung function and laboratory indicators. As it included studies with relatively small sample size, the findings require confirmation by further rigorously well-designed RCTs.

Clinical Observation on Removing both Phlegm and Blood Stasis Therapy in Treating Connective Tissue Disease Related Interstitial Lung Disease

Clinical Observation on Alcoholic Cirrhosis Treated with Method for Dissipating Phlegm and Removing Blood Stasis

Observation of Therapeutic Effects of Dachengqi Decoction Combined with Recruitment Maneuver on Patients with Extra-pulmonary Acute Respiratory Distress Syndrome

Clinical observation of Tetrandrine in treating pulmonary interstitial fibrosis caused by connective tissue disease

Curative Effect Observation of Blood Stasis Type LDH by Acupuncture with Plum Needle Stab Heavy Knock Cupping Bloodletting Therapy

Therapeutic effect of ipratropium bromide combined with long-term domiciliary oxygen therapy for patients with chronic obstructive pulmonary disease

[Clinical Observation on Chronic Obstructive Pulmonary Disease of Acute Aggravating Stage Treated with Activating Blood Circulation to Remove Blood Stasis Recipe].

Effects of Qi-supplementing, Blood-activating And Phlegm-resolving on Lung Function And Blood Coagulationin Among Patients of Chronic Obstructive Pulmonary Disease in Acute Stage

Analysis on Clinical Materials from 76 Cases of COPD Treated with Qi-Replenishing, Blood-Activating and Phlegm-Removing Therapy

Clinical efficacy of TCM formula of replenishing qi and resolving phlegm and dispelling stasis on patients with stable chronic obstructive pulmonary disease

Clinical manifestations of connective tissue diseases complicated with interstitial lung disease:an analysis of 90 cases

Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis

Efficacy and safety of oral versus intravenous cyclophosphamide in treatment of connective tissue disease‐related interstitial lung disease

Effect of integrative Chinese and western medicine on acute exacerbation of chronic obstructive pulmonary disease combined with respiratory failure

Application of Acupoint Catgut Embedding Therapy Combined with Liuzijue Breathing Exercise in the Treatment of Patients with Stable Chronic Obstructive Pulmonary Disease

Clinical Observation on efficacy of Infrared Therapeutic Apparatus on Hepatopathy with Acupuncture in Treating Cirrhosis Patients at Compensatory Phase of Liver-Qi-Stagnation and Spleen-Deficiency Pattern

Expression and clinical significance of biomarkers in serum and bronchoalveolar lavage fluid from patients with connective tissue disease-associated interstitial lung disease

Clinical Observation of Treating Dyslipidemia Accumulation of Phlegm Stasis with Danggui Shaoyao San

Clinical Research on 178 Cases of Chronic Obstructive Pulmonary Disease in T He Stable Stage Treated with Jianpi Yifei II

Characteristics and Survival of Connective Tissue Disease Associated Pulmonary Arterial Hypertension Patients with and Without Interstitial Lung Disease

Clinical Efficacy Observation of Acetylcysteine Combined with Tiotropium Bromide Inhalation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease